When the Treatment is the Cause: Disseminated Bacille Calmette-Guérin Infection
Ana Teresa Marques Afonso1, Montserrat Rodríguez Framil1, Joaquín Sánchez Leira1
1Internal Medicine Department, University Hospital of Santiago de Compostela, A Coruña, Spain.
European Journal of Case Reports in Internal Medicine
|September 10, 2020
Summary
Systemic complications from Bacillus Calmette-Guérin (BCG) immunotherapy for superficial bladder cancer are rare but possible. Vigilance for symptoms like fever and weight loss, alongside treatment response evaluation, is crucial for timely diagnosis.
Area of Science:
- Oncology
- Immunotherapy
- Urology
Background:
- Bacille Calmette-Guérin (BCG) is a standard, effective treatment for superficial bladder cancer.
- While generally safe, BCG immunotherapy can rarely cause unpredictable systemic complications.
- Patient symptoms following treatment necessitate careful evaluation.
Purpose of the Study:
- To highlight a rare systemic complication of BCG immunotherapy.
- To emphasize the importance of clinical suspicion and diagnostic tools in identifying BCG-related adverse events.
- To underscore the need for monitoring treatment response.
Main Methods:
- Case report presentation.
- Clinical evaluation including patient history (fever, asthenia, weight loss).
- Diagnostic imaging (computed tomography scan).
Main Results:
- A patient presented with systemic symptoms post-BCG immunotherapy.
- Clinical assessment and computed tomography scanning were instrumental in diagnosing the complication.
- The case illustrates an uncommon but significant adverse event associated with BCG therapy.
Conclusions:
- Maintaining a high index of suspicion for uncommon BCG immunotherapy complications is essential.
- Evaluating the patient's response to treatment aids in confirming diagnostic suspicion.
- Prompt recognition and diagnosis are key for managing patients undergoing BCG immunotherapy.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.9K
09:23Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019
12.3K
Related Concept Videos
01:31Pulmonary Tuberculosis III
699
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
699
01:28Pulmonary Tuberculosis II
1.1K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.1K
01:28Pulmonary Tuberculosis V
375
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
375
01:29Pulmonary Tuberculosis I
623
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
623
01:26Pulmonary Tuberculosis IV
330
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
330